PACTR201312000722390
Recruiting
未知
ANTIRETROVIRALS FOR HIV PREVENTION AND TREATMENT AMONG ZIMBABWEAN SEX WORKERS
Centre for Sexual Health and HIV/AIDS Research Zimbabwe0 sites2,800 target enrollmentDecember 9, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Centre for Sexual Health and HIV/AIDS Research Zimbabwe
- Enrollment
- 2800
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •¿Age 18 or older
- •¿Currently working as a sex worker (has exchanged sex for money in the past 30 days)
- •¿Living or working in the study site (for at least 6 month)
Exclusion Criteria
- •¿Already participated in the current round of survey
- •¿Visiting the study site temporarily (for less than 6 month)
- •¿Not currently working as a sex worker (verification questions will be used to prevent fraudulent participation, such as about how sex work is organised in the area and the cost of different sex acts)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
PROJECT ¿SABES?”PER-066-14Centro de Investigacion del Cancer Fred Hutchinson, Estados Unidos,2,138
Unknown
Not Applicable
HIV TESTING AND TREATMENT TO PREVENT ONWARD HIV TRANSMISSION AMONG FOR MEN WHO HAVE SEX WITH MEN AND TRANSGENDER WOMEN IN LIMA, PERPER-095-12Centro de Investigacion del Cancer Fred Hutchinson, Estados Unidos,
Completed
Not Applicable
Highly active anti-retroviral therapy including nevirapine once daily versus twice daily after at least 12 weeks of nevirapine twice daily. A randomized, open, multicentre trial.ISRCTN81305260Institute of Biomedical Investigations of Bellvitge (Institut d'Investigació Biomèdica de Bellvitge) (IDIBELL) (Spain)308
Completed
Phase 4
Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in AfricaHIVNCT01088516University of Zambia280
Completed
Not Applicable
Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trialISRCTN48682427Ministry of Health (Brazil)